Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
No matches found
Show only United States results
Show subsections
IND
USA
MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : MAJOR PHARMACEUTICALS
SAREPTA THERAPEUTICS INC
Sarepta Therapeutics Inc
XNAS: SRPT
Expensive Underperformer
Download real time
16.75
0.92
(
5.81
%)
New 52W Low in past week
39.1M
XNAS Volume
High volume+gain today
XNAS
30 Jul, 2025 5:30 PM (EDT)
Watchlist
Portfolio
Alert
Share
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
My Notes
USFDA Approval
Sarepta rises on Wednesday as USFDA allows it to resume shipments of its gene therapy drug Elevidys
See details
Overview
Buy Sell Zone
Financials
Forecaster
Competitors/Peers
Quarterly Results
Annual Results
Balance Sheet
Financial Ratios
Cash Flow
Technicals
Share Price History
Ownership
Insider Deals
Corporate Actions
All
Dividend
Split
Board Meetings
About
Sarepta Therapeutics Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents